Metraipolis › archive › dc_50da191cb35a

Metabolic dysfunction-associated steatohepatitis exacerbated by Clostridium perfringens-derived ammonia is attenuated by tripeptide DT-109 — Europe PMC PMID:42118590

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42118590
DOI
10.1172/jci200522
License (as archived)
solo-consultazione
Archived
2026-11-02T09:28:43.531Z
SHA-256 of the archived text
38eba71059b9048e33890dc49d240b21d71b7ed2a3c47aebf10b888a844155d5
Stable URL of this page
https://metraipolis.com/documento/dc_50da191cb35a

How to cite

Metabolic dysfunction-associated steatohepatitis exacerbated by Clostridium perfringens-derived ammonia is attenuated by tripeptide DT-109 — Europe PMC PMID:42118590 — Europe PMC (en), https://europepmc.org/article/MED/42118590 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_50da191cb35a (Metraipolis archive dc_50da191cb35a, sha256 38eba71059b9048e33890dc49d240b21d71b7ed2a3c47aebf10b888a844155d5)
BibTeX
@misc{dc50da191cb35a,
  title = {Metabolic dysfunction-associated steatohepatitis exacerbated by Clostridium perfringens-derived ammonia is attenuated by tripeptide DT-109 — Europe PMC PMID:42118590},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42118590},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_50da191cb35a; sha256 38eba71059b9048e33890dc49d240b21d71b7ed2a3c47aebf10b888a844155d5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42118590. Agents can read the archived copy with the MCP tool read_document.